J2 Capital Management’s Medpace MEDP Stock Holding History

J2 Capital Management’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$890K	Buy	1,681 +595	+55%	+$275K	0.6%	26
2026 Q1	$521K	Buy	+1,086	New	+$556K	0.36%	77

Other funds holding MEDP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

J2 Capital Management's MEDP Position: Q2 2026 in Review

J2 Capital Management increased its Medpace (MEDP) stake by 55% in Q2 2026, buying an estimated $275K and bringing the position to 1,681 shares worth $890K. The position accounts for 0.6% of the portfolio, ranked #26.

J2 Capital Management first reported a position in MEDP in Q1 2026 and has held it in 2 quarters since. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

J2 Capital Management held 1,681 shares of Medpace worth $890K as of Q2 2026.
J2 Capital Management bought 595 Medpace shares in Q2 2026, an estimated $275K.
Medpace made up 0.6% of J2 Capital Management's portfolio in Q2 2026, its #26 holding.
J2 Capital Management first reported a position in Medpace in Q1 2026 and has held it in 2 quarters since.
697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on J2 Capital Management's 13F filing for Q2 2026, filed 20 Jul 2026.